Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release naproxen sodium for postsurgical dental pain
2014-005272-28Phase 3
- Sponsor
- Bayer
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Aprol in postoperative pain and odontalgia (3 arms), sponsored by Bayer. Primary endpoint: Summed, Time-weighted Pain Intensity Difference From 0 to 24 Hours Postdose.
02
Drugs
Aprol
03
Conditions
postoperative painodontalgia
Beyond the preview
Go deeper on 2014-005272-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005272-28.